ZA979726B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number: ZA979726B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 1996-10-31

Application number

ZA979726A

Other languages

English (en)

Inventor

Gary Wayne Goodson

Katherine Jeanette Ford

Allen Wayne Wood

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-31

Filing date

1997-10-29

Publication date

1999-04-29

1997-10-29 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1999-04-29 Publication of ZA979726B publication Critical patent/ZA979726B/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Biotechnology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)

ZA979726A 1996-10-31 1997-10-29 Pharmaceutical compositions ZA979726B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9622681.6A GB9622681D0 (en)	1996-10-31	1996-10-31	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
ZA979726B true ZA979726B (en)	1999-04-29

Family

ID=10802224

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA979726A ZA979726B (en)	1996-10-31	1997-10-29	Pharmaceutical compositions

Country Status (43)

Country	Link
EP (1)	EP0941100B1 (cs)
JP (1)	JP2001502718A (cs)
KR (1)	KR100551652B1 (cs)
AP (1)	AP1067A (cs)
AR (1)	AR009135A1 (cs)
AT (1)	ATE241364T1 (cs)
AU (1)	AU736607B2 (cs)
BG (1)	BG64541B1 (cs)
BR (1)	BR9712614A (cs)
CA (1)	CA2270174A1 (cs)
CO (1)	CO4930269A1 (cs)
CY (1)	CY2485B1 (cs)
CZ (1)	CZ296080B6 (cs)
DE (1)	DE69722433T2 (cs)
DK (1)	DK0941100T3 (cs)
EA (1)	EA002437B1 (cs)
EE (1)	EE03806B1 (cs)
ES (1)	ES2200204T3 (cs)
GB (1)	GB9622681D0 (cs)
GE (1)	GEP20022735B (cs)
GT (1)	GT199700116A (cs)
HR (1)	HRP970569B1 (cs)
HU (1)	HU224969B1 (cs)
ID (1)	ID18698A (cs)
IL (1)	IL129422A0 (cs)
IS (1)	IS5024A (cs)
MY (1)	MY119513A (cs)
NO (1)	NO317163B1 (cs)
NZ (1)	NZ335153A (cs)
OA (1)	OA11038A (cs)
PA (1)	PA8441101A1 (cs)
PE (1)	PE10099A1 (cs)
PL (1)	PL190349B1 (cs)
PT (1)	PT941100E (cs)
SI (1)	SI0941100T1 (cs)
SK (1)	SK284286B6 (cs)
SV (1)	SV1997000090A (cs)
TR (1)	TR199900950T2 (cs)
UA (1)	UA64725C2 (cs)
UY (1)	UY24766A1 (cs)
WO (1)	WO1998018477A2 (cs)
YU (1)	YU19999A (cs)
ZA (1)	ZA979726B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9622681D0 (en) *	1996-10-31	1997-01-08	Glaxo Group Ltd	Pharmaceutical compositions
GB9809213D0 (en) *	1998-04-29	1998-07-01	Glaxo Group Ltd	Pharmaceutical compositions
US7074417B2 (en) *	2000-10-13	2006-07-11	Advancis Pharmaceutical Corporation	Multiple-delayed release anti-viral product, use and formulation thereof
AU2002311622A1 (en) *	2002-04-23	2003-11-10	Lupin Limited	Long acting compositions comprising zidovudine and lamivudine
US20050287177A1 (en) *	2002-11-08	2005-12-29	Glaxo Group Unlimited And Smithkline Beecham Corp.	Pharmaceutical compositions
MXPA05007016A (es)	2003-01-14	2005-09-12	Gilead Sciences Inc	Composiciones y metodos para terapia antiviral de combinacion.
AR045841A1 (es) *	2004-09-28	2005-11-16	Richmond Sa Com Ind Y Financie	Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r, 8r, 10r,11r)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla.
CN114010776A (zh)	2010-06-09	2022-02-08	疫苗技术股份有限公司	用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
IN2014MN01907A (cs)	2012-03-05	2015-07-10	Cipla Ltd
EP2958563A2 (en) *	2013-02-20	2015-12-30	AbbVie Inc.	Tablet dosage form comprising ritonavir and lopinavir
JP2023010676A (ja) *	2021-07-09	2023-01-20	株式会社東洋新薬	固形組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4950652A (en) *	1987-03-23	1990-08-21	Hem Research, Inc.	dsRNAs for combination therapy in the treatment of viral diseases
GB9110624D0 (en) *	1991-05-16	1991-07-03	Glaxo Group Ltd	Combinations
WO1992020344A1 (en) *	1991-05-16	1992-11-26	Glaxo Group Limited	Antiviral combinations containing nucleoside analogs
GB9622681D0 (en) *	1996-10-31	1997-01-08	Glaxo Group Ltd	Pharmaceutical compositions

1996
- 1996-10-31 GB GBGB9622681.6A patent/GB9622681D0/en active Pending
1997
- 1997-10-24 HR HR970569A patent/HRP970569B1/xx not_active IP Right Cessation
- 1997-10-28 SV SV1997000090A patent/SV1997000090A/es not_active Application Discontinuation
- 1997-10-28 MY MYPI97005103A patent/MY119513A/en unknown
- 1997-10-28 CO CO97063174A patent/CO4930269A1/es unknown
- 1997-10-29 HU HU0000344A patent/HU224969B1/hu not_active IP Right Cessation
- 1997-10-29 EP EP97950036A patent/EP0941100B1/en not_active Expired - Lifetime
- 1997-10-29 CA CA002270174A patent/CA2270174A1/en not_active Abandoned
- 1997-10-29 DK DK97950036T patent/DK0941100T3/da active
- 1997-10-29 BR BR9712614-4A patent/BR9712614A/pt not_active IP Right Cessation
- 1997-10-29 ZA ZA979726A patent/ZA979726B/xx unknown
- 1997-10-29 PL PL97333143A patent/PL190349B1/pl unknown
- 1997-10-29 KR KR1019997003757A patent/KR100551652B1/ko not_active Expired - Fee Related
- 1997-10-29 EA EA199900345A patent/EA002437B1/ru not_active IP Right Cessation
- 1997-10-29 EE EEP199900175A patent/EE03806B1/xx not_active IP Right Cessation
- 1997-10-29 PT PT97950036T patent/PT941100E/pt unknown
- 1997-10-29 TR TR1999/00950T patent/TR199900950T2/xx unknown
- 1997-10-29 JP JP10520045A patent/JP2001502718A/ja active Pending
- 1997-10-29 AP APAP/P/1999/001519A patent/AP1067A/en active
- 1997-10-29 YU YU19999A patent/YU19999A/sh unknown
- 1997-10-29 DE DE69722433T patent/DE69722433T2/de not_active Expired - Lifetime
- 1997-10-29 SI SI9730570T patent/SI0941100T1/xx unknown
- 1997-10-29 ES ES97950036T patent/ES2200204T3/es not_active Expired - Lifetime
- 1997-10-29 GE GEAP19974781A patent/GEP20022735B/en unknown
- 1997-10-29 NZ NZ335153A patent/NZ335153A/en unknown
- 1997-10-29 CZ CZ0155799A patent/CZ296080B6/cs not_active IP Right Cessation
- 1997-10-29 WO PCT/EP1997/005953 patent/WO1998018477A2/en not_active Ceased
- 1997-10-29 IL IL12942297A patent/IL129422A0/xx not_active IP Right Cessation
- 1997-10-29 AR ARP970105027A patent/AR009135A1/es unknown
- 1997-10-29 AU AU53142/98A patent/AU736607B2/en not_active Ceased
- 1997-10-29 UA UA99042239A patent/UA64725C2/uk unknown
- 1997-10-29 GT GT199700116A patent/GT199700116A/es unknown
- 1997-10-29 SK SK575-99A patent/SK284286B6/sk unknown
- 1997-10-29 AT AT97950036T patent/ATE241364T1/de active
- 1997-10-29 PE PE1997000965A patent/PE10099A1/es not_active Application Discontinuation
- 1997-10-30 PA PA19978441101A patent/PA8441101A1/es unknown
- 1997-10-30 UY UY24766A patent/UY24766A1/es not_active IP Right Cessation
- 1997-10-30 ID IDP973554A patent/ID18698A/id unknown
1999
- 1999-04-09 IS IS5024A patent/IS5024A/is unknown
- 1999-04-23 OA OA9900088A patent/OA11038A/en unknown
- 1999-04-29 NO NO19992091A patent/NO317163B1/no unknown
- 1999-05-26 BG BG103435A patent/BG64541B1/bg unknown
2004
- 2004-11-26 CY CY0400085A patent/CY2485B1/xx unknown

Also Published As

Publication number	Publication date
PL190349B1 (pl)	2005-11-30
PA8441101A1 (es)	2000-05-24
DK0941100T3 (da)	2003-09-01
CZ155799A3 (cs)	1999-10-13
BR9712614A (pt)	1999-10-26
IS5024A (is)	1999-04-09
UA64725C2 (uk)	2004-03-15
SK284286B6 (sk)	2005-01-03
PE10099A1 (es)	1999-03-02
IL129422A0 (en)	2000-02-17
TR199900950T2 (xx)	1999-07-21
EE03806B1 (et)	2002-08-15
PT941100E (pt)	2003-10-31
ID18698A (id)	1998-04-30
HUP0000344A2 (hu)	2001-05-28
AP1067A (en)	2002-05-01
WO1998018477A2 (en)	1998-05-07
OA11038A (en)	2002-02-06
KR20000052893A (ko)	2000-08-25
BG64541B1 (bg)	2005-07-29
PL333143A1 (en)	1999-11-22
JP2001502718A (ja)	2001-02-27
WO1998018477A3 (en)	1998-06-18
GEP20022735B (en)	2002-07-25
CO4930269A1 (es)	2000-06-27
EP0941100A2 (en)	1999-09-15
HRP970569B1 (en)	2004-10-31
EA002437B1 (ru)	2002-04-25
CZ296080B6 (cs)	2006-01-11
HUP0000344A3 (en)	2002-04-29
AU5314298A (en)	1998-05-22
EP0941100B1 (en)	2003-05-28
AP9901519A0 (en)	1999-06-30
NO992091D0 (no)	1999-04-29
YU19999A (sh)	2000-10-30
HRP970569A2 (en)	1998-08-31
AU736607B2 (en)	2001-08-02
UY24766A1 (es)	2000-12-29
ATE241364T1 (de)	2003-06-15
EE9900175A (et)	1999-12-15
DE69722433T2 (de)	2004-04-08
SV1997000090A (es)	1998-10-07
GB9622681D0 (en)	1997-01-08
HU224969B1 (en)	2006-04-28
NZ335153A (en)	2001-04-27
HK1020880A1 (en)	2000-05-26
SI0941100T1 (en)	2003-12-31
BG103435A (en)	2000-04-28
NO317163B1 (no)	2004-08-30
MY119513A (en)	2005-06-30
CY2485B1 (en)	2005-06-03
EA199900345A1 (ru)	2000-02-28
AR009135A1 (es)	2000-03-08
KR100551652B1 (ko)	2006-02-13
CA2270174A1 (en)	1998-05-07
SK57599A3 (en)	2000-06-12
ES2200204T3 (es)	2004-03-01
NO992091L (no)	1999-06-29
DE69722433D1 (de)	2003-07-03
GT199700116A (es)	1999-04-22

Publication	Publication Date	Title
EG24118A (en)	2008-07-06	Pharmaceutical compositions
GB9727053D0 (en)	1998-02-18	Pharmaceutical compositions
GB9616672D0 (en)	1996-09-25	Pharmaceutical compositions
ZA9710006B (en)	1999-06-05	Novel pharmaceutical compositions
GB9610359D0 (en)	1996-07-24	Pharmaceutical compositions
IL131917A0 (en)	2001-03-19	Pharmaceutical compositions
IL131995A0 (en)	2001-03-19	Gastric-retained pharmaceutical compositions
ZA979726B (en)	1999-04-29	Pharmaceutical compositions
GB9723985D0 (en)	1998-01-14	Pharmaceutical compositions
HUP0004669A3 (en)	2005-03-29	Pharmaceutical compositions
GB9606429D0 (en)	1996-06-05	Pharmaceutical compositions
GB9613457D0 (en)	1996-08-28	Pharmaceutical compositions
GB9623962D0 (en)	1997-01-08	Pharmaceutical composition
HU9700632D0 (en)	1997-05-28	Pharmaceutical compositions
GB9610136D0 (en)	1996-07-24	Pharmaceutical compositions
GB9618376D0 (en)	1996-10-16	Pharmaceutical compositions
HUP0003528A3 (en)	2001-07-30	Pharmaceutical compositions containing dihydropolyprenols
ZA982117B (en)	1998-09-14	Pharmaceutical compositions
GB2308545A (en)	1997-07-02	Pharmaceutical compositions
GB9718270D0 (en)	1997-11-05	Pharmaceutical compositions
GB9603942D0 (en)	1996-04-24	Pharmaceutical compositions
GB9606586D0 (en)	1996-06-05	Pharmaceutical compositions
SI0941095T1 (en)	2004-12-31	Improved pharmaceutical compositions
GB9623225D0 (en)	1997-01-08	Novel pharmaceutical compositions
ZA962792B (en)	1996-12-31	Pharmaceutical composition